Whole Exome Sequencing Global Market Report 2024

Description

“Whole Exome Sequencing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on whole exome sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for whole exome sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The whole exome sequencing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product: Systems; Kits; Services
2) By Technology: Sequencing By Synthesis; Ion Semiconductor Sequencing; Other Technologies
3) By Application: Diagnostics; Drug Discovery And Development; Personalized Medicine; Agriculture And Animal Research
4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Academic and Research Institutes; Clinical Laboratories; Other End-Users
Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Eurofins Genomics; Azenta US Inc.; CD Genomics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Whole exome sequencing is a genomic sequencing method that involves sequencing all the protein-coding regions within a genome. This laboratory technique is utilized to identify mutations that could be linked to a specific disease.

The primary offerings in the field of whole exome sequencing include systems, kits, and services. The term "system" pertains to the examination of how biological components such as molecules, cells, and organs interact and function. Various technologies, such as sequencing by synthesis, ion semiconductor sequencing, and others, are employed for applications in diagnostics, drug discovery and development, personalized medicine, agriculture, and animal research. These applications are utilized by hospitals and clinics, pharmaceutical and biotechnology companies, academic and research institutes, clinical laboratories, and other entities.

The whole exome sequencing market research report is one of a series of new reports from The Business Research Company that provides whole exome sequencing market statistics, including the whole exome sequencing industry global market size, regional shares, competitors with a whole exome sequencing market share, detailed whole exome sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the whole exome sequencing industry. This whole exome sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The whole exome sequencing market size has grown rapidly in recent years. It will grow from $2.34 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 19.9%. The expansion observed in the historical period can be ascribed to advancements in genomic research, the adoption of precision medicine trends, the diagnosis of rare diseases, applications in pharmaceutical and biotech sectors, and the decreasing costs associated with sequencing.

The whole exome sequencing market size is expected to see exponential growth in the next few years. It will grow to $5.89 billion in 2028 at a compound annual growth rate (CAGR) of 20.4%. The anticipated expansion in the forecast period can be linked to the increasing applications in oncology, the integration into clinical diagnostics, a surge in demand for genetic testing, initiatives in population genomics, and the emergence of gene therapies. Key trends expected in the forecast period encompass improved clinical utility and adoption, decreasing sequencing costs, emphasis on data security and privacy, integration with electronic health records, and advancements in single-cell sequencing.

The anticipated growth in the whole exome sequencing market is expected to be propelled by the increasing prevalence of HIV (human immunodeficiency virus). HIV is a virus that targets the body's immune system, and whole exome sequencing is employed to provide genomic structures of viruses, facilitating personalized treatment and vaccine designs for HIV. As of April 2023, the World Health Organization reported that HIV remains a significant global public health concern, with 38.4 million patients worldwide in 2021 and 650,000 deaths from HIV-related causes. Consequently, the escalating prevalence of HIV is a key driver for the growth of the whole exome sequencing market.

The rising demand for personalized medicine is also poised to drive the growth of the whole exome sequencing market. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, offering more effective and precise healthcare interventions. Whole exome sequencing is integral to personalized medicine, enabling the customization of treatments based on an individual's genetic profile for precise and targeted therapies. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% (12 of them) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the increasing demand for personalized medicine is a significant factor contributing to the growth of the whole exome sequencing market.

A prominent trend gaining traction in the whole exome sequencing market is the adoption of innovative diagnostic techniques. Companies within this market are actively engaged in developing new product innovations to maintain their market positions. For example, in February 2023, Illumina Inc., a biotechnology company based in the United States, introduced the NovaSeqX Plus, a state-of-the-art sequencing technology. This groundbreaking technology combines high throughput and accuracy, featuring streamlined informatics, sustainability advancements, and cost-effective sequencing. The NovaSeq X Plus systems are equipped with innovations capable of generating tens of thousands of whole genomes annually, enhancing productivity, and minimizing turnaround time.

Major players in the whole exome sequencing market are concentrating on the development of advanced solutions to enhance diagnostic capabilities in complex and unsolved patient cases. These advanced whole exome sequencing solutions entail comprehensive analysis of the protein-coding regions of the genome, offering detailed insights into genetic variations associated with diseases, traits, and individual characteristics. This aids in precise diagnostics and facilitates personalized medicine approaches. In June 2021, Centogene N.V., a German-based company, launched the CentoXome, an enhanced next-generation sequencing-based assay. Paired with life-long diagnostic support and a free-of-charge proactive reclassification program, CentoXome analyzes an individual's DNA to identify potential genetic variations, mutations, or markers linked to specific diseases, conditions, or traits. These tests serve various purposes, including identifying inherited disorders, assessing susceptibility to certain diseases, or exploring ancestry.

In January 2022, Exact Sciences, a molecular diagnostics company in the United States, acquired Prevention Genetics for a deal valued at $190 million. This strategic acquisition strengthened Exact Sciences' advanced cancer testing portfolio. Prevention Genetics, a clinical DNA testing laboratory based in the U.S., is known for providing high-quality genetic testing and services to patients and researchers.

Major companies operating in the whole exome sequencing market report are Thermo Fisher Scientific Inc.,Illumina Inc.,Eurofins Genomics,Azenta US Inc.,CD Genomics,Psomagen Inc.,Agilent Technologies,BGI Genomics,F. Hoffmann-La Roche Ltd.,QIAGEN Inc.,Macrogen Inc.,Ambry Genetics,Bio-Rad Laboratories Inc.,Bioneer Corporation,Foundation Medicine Inc.,KONICA MINOLTA INC.,Otogenetics Corporation,Geneyx Genomex Ltd.,ArcherDX Inc.,Blueprint Genetics Oy,Bionano Genomics Inc.,Centogene AG,Fulgent Genetics Inc.,Natera Inc.,GeneDx Inc.,GENEWIZ Inc.,Novogene Corporation,PerkinElmer Inc.,Personalis Inc.,Clinicient Inc.

North America was the largest region in the whole exome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the whole exome sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The whole exome sequencing market consists of revenues earned by entities by providing services such as exome capture, library construction, deep sequencing, raw data quality control, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The whole exome sequencing market also includes sales of instruments, comparison tools, and sequencing reagents which are used in providing whole exome sequencing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12196

1. Executive Summary

2. Whole Exome Sequencing Market Characteristics

3. Whole Exome Sequencing Market Trends And Strategies

4. Whole Exome Sequencing Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Whole Exome Sequencing Market Size and Growth

5.1. Global Whole Exome Sequencing Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Whole Exome Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Whole Exome Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Whole Exome Sequencing Market Segmentation

6.1. Global Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Systems
Kits
Services
6.2. Global Whole Exome Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Sequencing By Synthesis
Ion Semiconductor Sequencing
Other Technologies
6.3. Global Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Diagnostics
Drug Discovery and Development
Personalized Medicine
Agriculture and Animal Research
6.4. Global Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Clinical Laboratories
Other End-Users

7. Whole Exome Sequencing Market Regional And Country Analysis

7.1. Global Whole Exome Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Whole Exome Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Whole Exome Sequencing Market

8.1. Asia-Pacific Whole Exome Sequencing Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Whole Exome Sequencing Market

9.1. China Whole Exome Sequencing Market Overview
9.2. China Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Whole Exome Sequencing Market

10.1. India Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Whole Exome Sequencing Market

11.1. Japan Whole Exome Sequencing Market Overview
11.2. Japan Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Whole Exome Sequencing Market

12.1. Australia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Whole Exome Sequencing Market

13.1. Indonesia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Whole Exome Sequencing Market

14.1. South Korea Whole Exome Sequencing Market Overview
14.2. South Korea Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Whole Exome Sequencing Market

15.1. Western Europe Whole Exome Sequencing Market Overview
15.2. Western Europe Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Whole Exome Sequencing Market

16.1. UK Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Whole Exome Sequencing Market

17.1. Germany Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Whole Exome Sequencing Market

18.1. France Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Whole Exome Sequencing Market

19.1. Italy Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Whole Exome Sequencing Market

20.1. Spain Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Whole Exome Sequencing Market

21.1. Eastern Europe Whole Exome Sequencing Market Overview
21.2. Eastern Europe Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Whole Exome Sequencing Market

22.1. Russia Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Whole Exome Sequencing Market

23.1. North America Whole Exome Sequencing Market Overview
23.2. North America Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Whole Exome Sequencing Market

24.1. USA Whole Exome Sequencing Market Overview
24.2. USA Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Whole Exome Sequencing Market

25.1. Canada Whole Exome Sequencing Market Overview
25.2. Canada Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Whole Exome Sequencing Market

26.1. South America Whole Exome Sequencing Market Overview
26.2. South America Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Whole Exome Sequencing Market

27.1. Brazil Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Whole Exome Sequencing Market

28.1. Middle East Whole Exome Sequencing Market Overview
28.2. Middle East Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Whole Exome Sequencing Market

29.1. Africa Whole Exome Sequencing Market Overview
29.2. Africa Whole Exome Sequencing Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Whole Exome Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Whole Exome Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Whole Exome Sequencing Market Competitive Landscape And Company Profiles

30.1. Whole Exome Sequencing Market Competitive Landscape
30.2. Whole Exome Sequencing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Illumina Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Eurofins Genomics
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Zaneta US Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. CD Genomics
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Whole Exome Sequencing Market Competitive Benchmarking

32. Global Whole Exome Sequencing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Whole Exome Sequencing Market

34. Whole Exome Sequencing Market Future Outlook and Potential Analysis

34.1 Whole Exome Sequencing Market In 2028 - Countries Offering Most New Opportunities
34.2 Whole Exome Sequencing Market In 2028 - Segments Offering Most New Opportunities
34.3 Whole Exome Sequencing Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer